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Abstract 
Background: Bradford city has high infant mortality and there is a major health concern in the 
community due to environmental pollution. The aim of the study was to investigate the incidence and 
burden of wheezing disorders, eczema and rhinitis in in children aged 3-7 years. 
Methods: it is a prospective cohort study; the participants were 13,734 children from the Born in 
Bradford cohort.  
Results: There were a total of 22.1% (95% CI: 21.4 to 22.8%), 52.4% (95% CI: 51.5 % to 53.2%) and 
19.3% (95% CI: 18.6 to 19.9%) incidence cases of wheezing disorders, eczema and rhinitis, respectively. 
A total of 37% (95% CI: 36.2% to 37.8%), 19.5% (95% CI: 18.9% to 20.2%) and 5.9% (95% CI: 5.5% 
to 6.3%) of the children were affected by only-one, two and three diseases, respectively. Boys to girls 
incidence rate ratios for wheezing disorders, eczema and rhinitis was 1.41 (95% CI: 1.31 to 1.51), 1.02 
(95% CI: 0.97 to 1.07) and 1.18 (95% CI: 1.09 to 1.28) respectively. The respective incidence rate ratios 
of Pakistani to white British were 0.94 (95% CI: 0.87 to 1.02), 1.31 (95% CI: 1.24 to 1.39) and 2.03 
(95% CI: 1.83 to 2.25) respectively. 
Conclusion: our study shows that the impact of wheezing disorders, eczema and rhinitis is substantial 
in this cohort and higher than previously reported in earlier studies. In addition, it indicates that whilst 
boys are more likely to suffer from wheezing disorders, rhinitis and multiple diseases than girls, 
Pakistani children are more likely to suffer from eczema, rhinitis and multiple diseases than white 
British children. 
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INTRODUCTION 
Wheezing disorders, eczema and rhinitis are global health problems and their prevalence was observed 
to rise in the last decades (1-3). Based on self-reported symptoms, the International Study of Asthma 
and Allergies in Childhood (ISAAC) reported that the global prevalence of asthma, rhinitis and eczema 
for 6-7 age group during 2002-2003 was 12.6% (range =2.8±37.6%), 8.5% (range = 2.2±24.2%) and 
8.9% (range =2±22.3%), respectively (1). The respective prevalence for the 13-14 age groups was 14.1% 
(range = 3.4±31.2%), 14.8% (range = 4.5±45.1%) and 8.1% (range = 1.4±21.8%). The UK was among 
the highest affected countries in the world with 12-months period prevalence of 20.9%, 10.1% and 16% 
for asthma, rhinitis and eczema symptoms in the 6-7 age group. The respective prevalence for the 13-
14 age group was 24.7% 15.3% and 14.7% (1). 
In the United Kingdom (UK), it is estimated that 1 in 5 and 1 in 11 children suffer from eczema (4) and 
asthma (5), respectively. Although figures for eczema and rhinitis are not available, there were 1.1 
million childhood asthma cases with around 25,000 emergency hospital admissions in 2012 (5). It is 
also estimated that the National Health Service (NHS) spends £1 billion a year treating and caring for 
childhood and adult asthma cases (5). 
Bradford district, populated by around half a million residents mainly white British and Pakistani 
(mostly from the Mirpuri region of Pakistan), is one of the most deprived areas in the UK (6, 7). The 
GLVWULFW¶V SRSXODWLRQ LV \RXQJHU WKDQ WKH QDWLRQDO DYHUDJH (6); and, while only around 18% of the 
residents are Pakistani origin (7), around 44% babies born in the district are from Pakistani origin 
mothers (6). Bradford has twice the national average infant mortality and relatively high childhood 
morbidity (8, 9), with childhood asthma presenting a major health concern in the community due to 
environmental pollution (7). In response to these health concerns in the district, Born in Bradford (BiB) 
cohort project was established in 2007 (7). The aim of the project was to examine the impact of genetic, 
nutritional, environmental, behavioural and social factors on child health and development, and adult 
life (7).  
 
The aim of the study was to investigate the burden of wheezing disorders, eczema, and rhinitis in the 
Born in Bradford (BiB) cohort. The study will also compare the burden of the three diseases among the 
two ethnicities (i.e. white British and Pakistani) as well as boys and girls.   
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METHODS: 
Study participants 
The Born in Bradford study is a prospective cohort, mainly bi-ethnic, that examines the impact of 
environmental, genetic and social factors on health of the population of Bradford (7). The methods of 
recruitment are explained in detail elsewhere Kingdom (6, 7). In brief: all women booked for delivery 
at the Bradford Royal Infirmary were offered an oral glucose tolerance test (OGTT) at 26±28 weeks 
gestation. Eighty percent of them agreed to do OGTT. Between March 2007 and December 2010, 
80% of those who attended for OGTT also agreed to participate in the BiB cohort. A total of 12,453 
mothers were recruited which resulted in 13,776 pregnancies. Out of the total births, 123 died before 
the age of 1 week and a total of 13 734 children were included in this analysis. 
Ethics statement 
Ethics approval was granted to the Born in Bradford project by Bradford Research Ethics Committee 
(Ref 07/H1302/112.). 
Data collection 
Three data sources were used. (a) Baseline questionnaire for information on ethnicity of the mother (i.e., 
SUR[\IRUFKLOG¶VHWKQLFLW\; (b)  the hospital maternity records for sex and birth year of a child and (c) 
information on wheezing disorders, eczema, and rhinitis drug prescription were collected from the 
systmOne primary care data.  
SystmOne is an integrated system with four modules: primary care, secondary care, mental health and 
social care (10). The systmOne primary care module allows clinicians to record and access patient data 
during consultation. It is currently used by more than 2500 General Practices (GPs) in England and all 
84 GPs in Bradford district areas (10).  
Baseline questionnaire and hospital maternity data were directly available from the data and research 
team of the BiB project (http://www.borninbradford.nhs.uk/our-team/) upon request. However, 
collection of drug prescription data was conducted in two steps. First, a list of drug family names and 
chapters were extracted from the British National Formulary (BNF) for Children Handbook version 
2015 and were given to the data manager of BiB project. Based on the list of drug names and chapters 
the BiB data manager then conducted a SystmOne query and extracted the data. The baseline 
questionnaire, maternity and drug SUHVFULSWLRQGDWDZHUHWKHQPHUJHGXVLQJµFKLOG,'¶DV an identifier 
variable. 
Case definition and ascertainment 
Incidence of wheezing disorders, eczema and rhinitis was confirmed through questionnaires or 
clinician-diagnosis data in the past. However, these types of data are prone to recall and reporting bias 
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respectively which are very likely to underestimate the true impact level of a disease in very young 
children. In order to overcome the potential for the misdiagnoses, a treatment based algorithm was used 
to allocate a diagnosis of disease conditions where wheezing disorder, eczema and rhinitis cases were 
ascertained by the existence of at least two respective drug prescriptions a minimum of one week and 
maximum of 12 months apart. A child can only be counted once as an incident case for each condition. 
Drug prescription primary care data was available up to November 2014. Supplementary Table 1 lists 
the drugs used to confirm the diagnosis of eczema, rhinitis and wheezing disorders. 
Statistical analysis and software 
Life-time prevalence was defined as the proportion of the cohort of children with diseases (i.e. wheezing 
disorders, eczema and rhinitis) during the follow up period which was calculated by dividing the total 
incident cases by the total number of the cohort of children at risk during the follow-up. Incidence rates 
were defined as the number of new cases of diseases per the cohort population at risk in a given time 
period calculated as the ratio of number of children diagnosed with the condition to the total person-
years at risk. Ethnicity, sex and birth year specific incidence rates were calculated as the ratio of number 
of children diagnosed with diseases for the particular birth year, ethnicity and sex to the respective total 
person-years at risk.  
Analyses of overall prevalence, incidence rates and incidence ratios were carried out on the 13,734 BiB 
FRKRUWFKLOGUHQ$VDVHQVLWLYLW\DQDO\VHV³ILYH-\HDUSHULRG´SUHYDOHQFHZHUHWKHQFDOFXODWHGIRUWKRVH
children with complete 5 year data. 
RESULTS 
The cohort consisted of 13,734 children born between April 2007 and June 2011. A total of 37.3% and 
32.8% were Pakistani and white British, respectively; and 17.4% of the cohort had their information on 
ethnicity missing and 12.6% of the cohort was from other ethnicities. The other ethnicities (12.6%) of 
the cohort was made up of 19 ethnicities all representing <2% of the total BiB cohort. A total of 50.4% 
and 47.3% were boys and girls, respectively, (Table 1). The cohort yielded a total follow up period of 
74,940 person years. The median follow up period was 5.55 years, ranging from 7 days to 7.6 years. Of 
the 13,734 cohort children, 140 had missing information on date of censoring, 225 withdrew from the 
study and 59 died during follow-up period.  
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Table 1   Cumulative number of incident cases and percentages for 13,734 BiB cohort children 
 Number of 
children (%) 
Allergic conditions (%) 
Wheezing disorders Eczema Rhinitis 
Overall  13,734 (100) 3,035 (22.1) 7,192 (52.4) 2,646 (19.3) 
Ethnicity      
 
Pakistani 5,117 (37.2) 1,150 (22.5) 2,995 (58.5) 1,255 (24.5) 
 
White British 4,501 (32.8) 1,074 (23.9) 2,010 (44.7) 543 (12.1) 
 
Other  1,733 (12.6) 308 (17.8) 948 (54.7) 352 (20.4) 
 
Missing 2,383 (17.4) 503 (21.1) 1,239 (52.0) 495 (20.8) 
Sex      
 
 
Boys 6,917 (50.4) 1,775 (25.7) 3,662 (52.9) 1,445 (20.9) 
Girls 6,490 (47.3) 1,190 (18.3) 3,382 (52.1) 1,150 (17.7) 
Missing 327 (2.3) 70 (21.4) 148 (45.3) 51 (15.6) 
Birth year    
 
2007 2,082 (15.2) 507 (24.4) 1,085 (52.7) 490 (23.5) 
 
2008 3,669 (26.7) 836 (22.8) 1,935 (53.0 779 (21.2) 
 
2009 3,817 (27.8) 872 (22.8) 2,021 (51.8) 725 (19.0) 
 
2010 3,432 (25.0) 693 (20.2) 1,779 (50.7) 551 (16.1) 
 
2011 734 (5.3) 127 (17.3) 372 (50.7) 101 (13.8) 
 
Wheezing disorders 
There were 3,035 incident cases (cumulative incidence = 22.1%, 95% CI: 21.4 to 22.8%) of wheezing 
disorder during the follow up period (Table 1). There was no significant difference in the cumulative 
incidence between white British (23.9%; 95% CI: 22.6% to 25%) and Pakistani (22.5%; 95% CI: 21.3% 
to 23.6%) children. However, boys (25.7%; 95% CI: 24.6% to 26.7%) were more likely to have been 
diagnosed with wheezing disorders than girls (18.3%; 95% CI: 17.4% to 19.3%) during the follow up 
period (Table 1).   
The overall incidence rate of wheezing disorders was 40.3 (95% CI: 38.9 to 41.8) per 1000 person years 
(Table 2). There was no significant difference between Pakistani and white British children (Incidence 
rate ratio = 0.94; 95% CI: 0.87 to 1.02). However, the rate was significantly higher for boys than girls 
(incidence rate ratio=1.41; 95% CI: 1.31 to 1.51), see Table 2. Although the cumulative incidence 
showed substantial decrease between 2007 and 2011 birth years (Table 1), there was a considerable 
increase in the incidence rate during the same period (Table 2). 
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Eczema 
There were a total of 7,192 (cumulative incidence: 52.4%, 95% CI: 51.5 % to 53.2%) childhood eczema 
incident cases during the follow up period (Table 1). There were more incident cases of Pakistani 
(58.5%; 95% CI: 57.2% to 59.9%) than the white British children (44.6%; 95% CI: 43.2% to 46.1%). 
However, there was no significant difference between boys (52.9%; 95% CI: 51.8% to 54.1%) and girls 
(52.1%; 95% CI: 50.9% to 53.3%), see Table 1.  
The overall incidence rate of eczema was 95.6 (95% CI: 93.4 to 97.9) per 1000 person years. The rate 
was significantly higher in Pakistani than the white British (1.31; 95% CI: 1.24 to 1.39), but no 
significant difference between boys and girls (Table 2). The incidence rate of eczema showed a 
consistent and substantial increase between 2007 and 2011 birth years (Table 2). 
Table 2  Age, birth year, ethnicity and sex specific person years and incidence rates of allergic 
conditions for 13,734 BiB cohort children 
 Incidence rate per 1000 person years (95% CI) 
Wheezing 
disorders 
Eczema Rhinitis 
Overall 40.3 (38.9 to 41.8) 95.6 (93.4 to 97.9) 35.3 (34.0 to 36.7) 
Ethnicity    
    White British 43.7 (41.2 to 46.4) 81.9 (78.4 to 85.6) 22.2 (20.4 to 24.2) 
     Pakistani 41.2(39.0 to  43.7) 107.4 (103.6 to 111.3) 45.0 (42.6 to 47.6) 
     Pakistani: white British 0.94 (0.87 to 1.03) 1.31 (1.24 to 1.39) 2.03 (1.83 to 2.25) 
Sex    
     Boys 46.8 (44.7 to 49) 96.5 (93.4 to 99.7) 38.2 (36.3 to 40.2) 
     Girls 33.3 (31.5 to 35.3) 94.8 (91.7 to 98) 32.3 (30.5 to 34.3) 
     Boys: girls 1.41 (1.31 to 1.51) 1.02 (0.97 to 1.07) 1.18 (1.09 to 1.28) 
Birth Year    
    2007 34.6 (31.7 to 37.7) 74.0 (69.7 to 78.6) 33.5 (30.7 to 36.6) 
    2008 36.3 (34.0 to 38.9) 84.1 (80.5 to 88.0) 33.9 (31.6 to 36.4) 
    2009 43.8 (41.0 to 46.8) 101.7 (97.3 to 106.2) 36.5 (34.0 to 39.3) 
    2010 46.4 (43.0 to 50.0) 119.2 (113.8 to 124.9) 37.1 (34.2 to 40.2) 
    2011 46.4 (39.0 to 55.3) 135.3 (122.2 to 149.8) 36.9 (30.4 to 44.9) 
 
Rhinitis 
There were 2,646 incident rhinitis cases (cumulative incidence: 19.3%; 95% CI: 18.6 to 19.9%) during 
the follow period (Table 1). There were more cases of rhinitis of Pakistani and boys than white British 
and girls, respectively (Table 1).  
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The overall incidence rate of rhinitis in the cohort was 35.3 (95% CI: 34.0 to 36.7) per 1000 person 
years. The incidence rate was higher in Pakistani and boys as compared white British and girls, 
respectively (Table 2). There was a slight but consistent increase in the incidence rates of rhinitis 
between 2007 and 2011 birth years (Table 2). 
Incidence of multiple diseases  
Of the overall cohort of 13,734 children, a total of 5,085 were affected by one of the three diseases; and, 
a total of 2,682 and 808 children had suffered from two and three diseases at the same time, respectively. 
The cumulative incidence for only one, two and three diseases was 37% (95% CI: 36.2% to 37.8%), 
19.5% (95% CI: 18.9% to 20.2%) and 5.9% (95% CI: 5.5% to 6.3%), respectively (Figure 1 and Table 
3). 
Table 3 Cumulative number of multiple incident cases and percentages for 13,734 BiB cohort 
children during the follow-up period 
 Number of 
children (%) 
Allergic conditions (%) 
One  
condition 
Two 
conditions 
Three 
conditions 
Overall  13,734 (100) 5,085 (37) 2,682 (19.5) 808 (5.9) 
Ethnicity      
 
Pakistani 5,117 (37.3) 1,963 (38.4) 1,144 (22.4) 383 (4.1) 
 
White British 4,501 (32.8) 1,647 (36.6) 711 (15.8) 186 (7.5) 
 
Other  1,733 (12.6) 628 (36.2) 348 (20) 95 (5.5) 
 
Missing 2,383 (17.4) 847 (35.5) 479 (20.1) 144 (6.0) 
Sex      
 
 
Boys 6,917 (50.4) 2,539 (36.7) 1,456 (21.0) 477 (6.9) 
Girls 6,490 (47.3) 2,444 (37.6) 1,174 (18.1) 310 (4.8) 
Missing 327 (2.3) 102 (31.2) 52 (15.9) 21 (6.4) 
Birth year    
 
2007 2,082 (15.2) 730 (35.1) 457 (22) 146 (7.0) 
 
2008 3,669 (26.7) 1,340 (36.5) 730 (19.9) 250 (6.8) 
 
2009 3,817 (27.8) 1,438 (37.7) 739 (19.4) 234 (6.1) 
 
2010 3,432 (25.0) 1,294 (37.7) 626 (18.2) 159 (4.6) 
 
2011 734 (5.3) 283 (38.6) 130 (17.7) 19 (2.6) 
 
Although Pakistani children were more likely to be diagnosed with one or two conditions than the white 
British, they were less likely to have three diseases simultaneously. Boys and girls were equally to have 
been diagnosed from a single condition, but, boys were more likely to be diagnosed from two and three 
diseases than girls (Table 3).  
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The overall incidence rate for at least one, two and three diseases was 67.5 (95% CI: 65.7 to 69.4), 35.7 
(95% CI: 34.4 to 37.1) and 10.8 (95% CI 10.1 to 11.5) per 1000 person years respectively. Boys and 
Pakistanis were more likely to be affected by multiple diseases than girls and white British children, 
respectively (Table 4). A consistent increase of trend in the incidence rate of single and two diseases 
between 2007 and 2011 birth years was observed (Table 4). 
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Table 4 Age, birth year, ethnic and sex specific person years and incidence rates of at least one 
and multiple allergic conditions 
 Incidence rate per 1000 person years (95% CI) 
One condition Two conditions Three conditions 
Overall 67.5 (65.7 to 69.4 ) 35.7 (34.4 to 37.1) 10.8 (10.1 to 11.5) 
Ethnicity    
    White British 67.2 ( 64.0 to 70.5) 29.0 (26.9 to 31.2) 7.6 (6.6 to 8.76) 
    Pakistani 70.3 (67.3 to 73.5 ) 41.0 (38.7 to 43.5) 13.7 (12.4 to 15.2) 
    Pakistani: white British 1.05 (0.98 to 1.12) 1.41 (1.29 to 1.56) 1.81 (1.52 to 2.17) 
Sex    
   Boys 66.8 (64.3 to 69.5) 38.4 (36.5 to 40.5) 12.6 (11.5 to 13.8) 
   Girls 68.5 (65.8 to 71.3) 32.9 (31.1 to 34.9) 8.7 (7.8 to 9.5) 
   Boys: Girls 1.02 (0.96 to 1.08) 1.17 (1.08 to 1.26) 1.45 (1.25 to 1.67) 
Birth Year    
   2007 49.7 (46.2 to 53.5) 31.3 (28.5 to 34.3) 9.9 (8.4 to 11.7) 
   2008 58.3 (55.2 to 61.5) 31.7 (29.5 to 34.1) 10.9 (9.6 to 12.3) 
   2009 72.2 (68.6 to 76.1) 37.2 (34.6 to 40.0) 11.8 (10.4 to 13.4) 
   2010 86.6 (82.0 to 91.5) 42.0 (38.8 to 45.4) 10.7 (9.2 to 12.5) 
   2011 102.8 (91.4 to 115.5) 47.5 (40.0 to 56.5) 6.9 (4.4 10.9) 
 
Five-year period prevalence 
Of the total 13,734 children, 9,079 (66.1%) had a complete follow-up from birth until 5 years. Of these, 
3,382 (37.2%) were Pakistani and 2,865 (31.6%) were white British children. 4,590 (50.6%) were boys 
and 4,298 (47.3%) were girls. Hence, there was no significant difference between the subset and the 
overall cohort. 
Of those 9,079 children, there were a total of 2,135 (23.5%), 4,867 (53.6%) and 1,939 (21.4%) prevalent 
cases of wheezing disorders, eczema and rhinitis, respectively (Supplementary Table 2). Eczema and 
rhinitis were more prevalent in Pakistani than the white British children, although there was no 
significant difference in wheezing disorders. All three diseases were more prevalent in boys than in 
girls (Supplementary Table 2).  
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COMMENTS 
In this prospective cohort study, the results indicate that 1 in 2 children have suffered from eczema, and 
1 in 5 children have suffered from wheezing disorders and rhinitis sometime between 0 and 7 years of 
age. A 37%, 19.5% and 5.9% of the children have suffered from only-one, two and three diseases, 
respectively. While there was no significant difference for eczema by gender, boys were more likely to 
suffer from wheezing disorders and rhinitis than girls. Furthermore, while no difference was observed 
for wheezing disorders, Pakistani children were more likely to suffer from eczema and rhinitis than 
white British children. Boys and Pakistani children were more likely to suffer from multiple diseases 
than girls and white British children, respectively. 
The five-year prevalence estimates suggest that 1 in 5 children will have been diagnosed with a 
wheezing disorder and rhinitis, when they reach the age of 5 years; and, 1 in 2 of the cohort have had 
eczema during the same period. Eczema and rhinitis were more prevalent in Pakistani than white British 
children, whilst all three diseases were more prevalent in boys than girls.  
In a meta-analysis and systematic review of studies conducted in the UK by Netuveli, Hurwitz (11) it 
was reported that 12-months period prevalence of asthma was lower in south Asian children (prevalence: 
7.6%; 95% CI: 3.7 to 11.4%) as compared with black (prevalence: 15%; 95% CI: 3.5 to 26.5%) and 
white (prevalence: 10.6; 95% 4.6 to 16.7%) children. These figures are significantly lower than any of 
the five-year prevalence (i.e. overall or ethnicity based figures) in this study which could be due to 
difference in the ethnic composition of the populDWLRQ GLDJQRVLV WHUPV XVHG LH µDVWKPD¶ YHUVXV
µZKHH]LQJGLVRUGHUV¶DQGWKHSUHYDOHQFHSHULRG,WZDVDOVRUHSRUWHGWKDWLQ3DNLVWDQWKHSUHYDOHQFH
of asthma, wheezing, eczema and rhinitis in school children of Karachi was 15.8%, 11.7%, 21.8% and 
28.5% respectively (12). The prevalence figures for rhinitis are similar to the BiB Pakistani group results 
DOWKRXJKLWPXVWEHQRWHGWKDWWKHDXWKRUVGHILQHGµZKHH]LQJ¶DQGµDVWKPD¶DVVHSDUDWHWHUPVDQGXVHG
questionnaires to confirm diagnoses of diseases. 
Punekar and Sheikh (13) who used the national General Practice Research Database (GPRD) data (14), 
reported lower incidence rates and lifetime prevalence than the BiB FRKRUW¶VILQGLQJV7KHLQFLGHQFH
rates for eczema, asthma and rhinitis were 22.7, 13.7 and 6.1 per 1000 person years, respectively. The 
18-year prevalence figures reported by the authors are also significantly lower for eczema (36.5%, 95% 
CI: 35.9 to 37.2%) and rhinitis (11.4%, 95% CI: 11.0 to 11.8%) while similar for wheezing disorders 
(22.9%, 95% 22.3 to 23.4%) when compared with the five-year prevalence of BiB cohort. These could 
be for two reasons. First, the authors used clinician-diagnosed diseases aQG µDVWKPD¶ LQVWHDG RI
µZKHH]LQJGLVRUGHUV¶+RZHYHUGUXJVFDQEHSUHVFULEHGIRUVRPHSHULRGRIWLPHDVDWULDOZLWKRXWDQ\
formal diagnosis (15). If the condition is transient, the child may not be formally diagnosed so this 
would underestimate the true burden of allergic diseases. In fact, in our previous work we found that 
although 22.1% of the children were treated for asthma drugs, only 6.1% of them were formally 
11 
 
diagnosed as asthmatic (16).Second, the GPRD data reflects the UK population and regions, but, the 
BiB data were composed of mainly Pakistani and white British who live in the district of Bradford. The 
district of Bradford has higher infant mortality (8), and air pollution has been a major concern in the 
community (7). Hence, the higher incidence of diseases in the BiB cohort than national level could be 
due to either difference in ethnic composition or higher environmental pollution. 
Although similar in direction, the cumulative incidence of wheezing disorder figures from the BiB 
cohort are moderately lower and higher than the Health Survey for England (HSE) figures for wheezing 
occurrence and doctor diagnosed asthma respectively. The HSE reported 30% and 23% cumulative 
incidence of wheezing occurrences in boys and girls respectively; and, 17% and 12% of cumulative 
incidence of doctor-diagnosed asthma for boys and girls respectively, in 0-15 year old children (17). 
The disparities could be due to longer follow up and the use of questionnaires to confirm wheezing 
occurrences and doctor-GLDJQRVHGDVWKPDLQ+6(¶VDQDO\VLVUHSRUW 
The findings of the BiB cohort are moderately different from the other three UK cohorts (18-20). For 
example, in a recent study that used data from the Millennium Cohort study 
(http://www.cls.ioe.ac.uk/page.aspx?sitesectionid=851) the lifetime prevalence at age 7 for eczema, 
wheeze and asthma were 42.9%, 25.8% and 15.1% respectively (21). Another recent study that used 
data from  the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort 
(http://www.bristol.ac.uk/alspac/) and the Manchester Asthma and Allergy Study (MAAS) cohort 
(http://www.maas.org.uk/) also reported that the prevalence of eczema, wheeze and rhinitis at five years 
of age were 24.4%, 18.4% and 2.3%, respectively, for ALSPAC cohort; and, 32.4%, 22.5% and 28.1, 
respectively, for MAAS cohort (22). The 5-years prevalence figures from the BiB cohort were slightly 
higher than the prevalence reported from the Millennium Cohort; and, moderately higher than the 
ALSPAC and MAAS cohort results. The variations in prevalence of allergic diseases between the BIB 
and the other UK cohorts could be due to the difference in ethnic composition and the use of 
questionnaire based data. 
From the cumulative incidence rates analysis of the BiB cohort based on the birth years, it can be noted 
that there was no significant change in the incidence rate of rhinitis during 2007-2011 (Table 2). 
However, there were substantial increases in the incidence rates of eczema during every subsequent 
birth year. The same pattern was also observed in the incidence rate of wheezing disorders although it 
plateaued between 2009 and 2011 birth years (Table 2). These results may indicate that either the impact 
of diseases has increased during those birth years (23-25) RUWKHUHPD\KDYHEHHQFKDQJHVLQFOLQLFLDQV¶
prescribing habits.  
The results of this study indicate that Pakistani children are more affected by eczema and rhinitis than 
the white British which may imply that there could be a genetic component in the causation of these 
diseases. The predominance of wheezing disorders and rhinitis in boys than girls may be difficult to 
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XQGHUVWDQGIRUWKH%L%FRKRUW¶VDJHJURXSDOWKRXJKWKHVDPHSDWWHUQZDVREVHUYHGXQWLOSXEHUW\DJHLQ
previous studies (26).  
The study has certain weaknesses and results need to be interpreted cautiously. First, in the analysis of 
incidence and burden of childhood diseases, there was a moderate proportion of missing information 
on ethnicity (17.4%) which could possibly have impacted the ethnic-specific incidence rate and ratio 
results. Second, recruitment was based on a willingness of the mothers to participate and study 
participants were those who were born at a single centre: the Bradford Royal Infirmary (BRI) maternity 
hospital. Births in the regional tertiary centre, home births and births in smaller hospitals outside 
Bradford will have been excluded. Third, the BiB cohort is mainly composed of white British and 
Pakistani children. While this could be a plus for comparative analyses between the two ethnicities, it 
was not possible to carry out comparative analyses for the other ethnicities. Fourth, the follow-up period 
for the cohort was also short (a maximum of 7 years) which could have impacted the incidence rate and 
ratio results as well as comparability with results from other cohorts that used longer follow-up periods. 
Fifth, although clinical records are best sources of data the possibility of errors during recording and 
consequently, disease outcome misclassification errors cannot be ruled out.  
Nonetheless, this study has strengths. First, the sample size of the study was sufficiently large. Second, 
clinical records were used in identifying cases of diseases. Clinical records have minimal 
misclassification errors in excluding cases as opposed to questionnaires and clinical diagnosis data. The 
drug and prescription data are entered onto the primary care database by the GPs at the time of 
consultation which is an incentive for records to be accurate. Third, unlike 12-months period or point 
prevalence which measure the disease burden during a limited period, lifetime prevalence figures 
provide a clearer picture about the burden of disease and are therefore more helpful for health policy 
makers. 
In conclusion, our study shows the impact of wheezing disorders, eczema and rhinitis is substantial in 
the Bradford district. In addition, it indicates that whilst boys are more likely to suffer from wheezing 
disorders, rhinitis and multiple diseases than girls, Pakistani children are more likely to suffer from 
eczema, rhinitis and multiple diseases than white British children. 
 
Acknowledgments: Born in Bradford is only possible because of the enthusiasm and commitment of 
the Children and Parents in BiB. We are grateful to all the participants, health professionals and 
researchers who have made Born in Bradford happen. 
Funding: Production of the manuscript was funded by Hall Dorman Research Scholarship. Data 
collection was funded by the National Institute for Health Research (NIHR) under the Collaborations 
13 
 
for Leadership in Applied Health Research and Care (CLAHRC) programme for Leeds, York and 
Bradford and the Programme Grants for Applied Research funding scheme.  
Contributors: TFM, RGF and RCP conceived the idea. TFM performed all the statistical analyses, 
interpretation of results and drafted the manuscript. RGF and RCP revised and commented on the 
manuscript. All authors approved the final version of the manuscript.  
Competing interests: none declared.  
14 
 
REFERENCES 
1. Asher MI, Montefort S, Björkstén B, Lai CKW, Strachan DP, Weiland SK, et al. Worldwide 
time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema 
in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. The 
Lancet. 2006;368(9537):733-43. 
2. Pearce N, Aït-Khaled N, Beasley R, Mallol J, Keil U, Mitchell E, et al. Worldwide trends in 
the prevalence of asthma symptoms: phase III of the International Study of Asthma and 
Allergies in Childhood (ISAAC). Thorax. 2007;62(9):758-66. 
3. Masoli M, Fabian D, Holt S, Beasley R, Global Initiative for Asthma P. The global burden of 
asthma: executive summary of the GINA Dissemination Committee Report. Allergy. 
2004;59(5):469-78. 
4. Eczema-UK. The National Eczema Society: What is Eczema? 2015 [Accessed 2015 02 
February]; Available from: http://www.eczema.org/what-is-eczema. 
5. Asthma-UK. [Accessed 2015 02 February]; Available from: 
http://www.asthma.org.uk/asthma-facts-and-statistics. 
6. Raynor P. Born in Bradford, a cohort study of babies born in Bradford, and their parents: 
Protocol for the recruitment phase. BMC public health. 2008;8(1):327. 
7. Wright J, Small N, Raynor P, Tuffnell D, Bhopal R, Cameron N, et al. Cohort Profile: The 
Born in Bradford multi-ethnic family cohort study. Int J Epidemiol. 2013;42(4):978-91. 
8. Bradford District Infant Mortality Commission (BDIMC). Bradford District Infant Mortality 
Commission Report 2006. Bradford District Infant Mortality Commission; 2007 [Accessed 
2015 May 20];;Available from: 
http://www.observatory.bradford.nhs.uk/SiteCollectionDocuments/Infant%20Mortality%20R
eport%202006.pdf. 
9. Bradford District Infant Mortality Commission (BDIMC). Bradford Joint Strategic Needs 
Assessment: Infant mortality in Bradford district. Bradford District Infant Mortality 
Commission; 2014 [Accessed 2015 May 22];Available from: 
http://www.observatory.bradford.nhs.uk/Documents/4_5_1_Infant_Mortality_2014.pdf. 
10. TPP. SystmOne.  [Accessed 27 June, 2016]; Available from: https://www.tpp-
uk.com/products/systmone. 
11. Netuveli G, Hurwitz B, Levy M, Fletcher M, Barnes G, Durham SR, et al. Ethnic variations in 
UK asthma frequency, morbidity, and health-service use: a systematic review and meta-
analysis. Lancet. 2005;365(9456):312-7. 
12. Hasnain SM, Khan M, Saleem A, Waqar MA. Prevalence of asthma and allergic rhinitis 
among school children of Karachi, Pakistan, 2007. J Asthma. 2009;46(1):86-90. 
15 
 
13. Punekar YS, Sheikh A. Establishing the incidence and prevalence of clinician-diagnosed 
allergic conditions in children and adolescents using routinely collected data from general 
practices. Clin Exp Allergy. 2009;39(8):1209-16. 
14. Walley T, Mantgani A. The UK General Practice Research Database. The Lancet. 
1997;350(9084):1097-9. 
15. Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and 
Prevention 2014. Chapter 6: Diagnosis and management of asthma in children 5 years and 
younger. 2015. 
16. Mebrahtu TF, Feltbower RG, Parslow RC. Effects of birth weight and growth on childhood 
wheezing disorders: findings from the Born in Bradford Cohort. BMJ Open. 2015;5(11). 
17. Boodhna G, Hall J. Health Survey for England 2010: Respiratory Symptoms and Asthma in 
children: The Health and Social care Information Centre; 2011 [Available from: 
http://www.hscic.gov.uk/catalogue/PUB03023/heal-surv-eng-2010-resp-heal-ch4-symp-
chil.pdf. 
18. Custovic A, Simpson BM, Murray CS, Lowe L, Woodcock A, on behalf of the NACMA, et 
al. The National Asthma Campaign Manchester Asthma and Allergy Study. Pediatr Allergy 
Immunol. 2002;13:32-7. 
19. Boyd A, Golding J, Macleod J, Lawlor DA, Fraser A, Henderson J, et al. Cohort Profile: The 
µ&KLOGUHQRIWKHV¶²the index offspring of the Avon Longitudinal Study of Parents and 
Children. Int J Epidemiol. 2012. 
20. Dex S, Joshi H. Children of the 21st century: from birth to nine months: Policy Press; 2005. 
21. Panico L, Stuart B, Bartley M, Kelly Y. Asthma trajectories in early childhood: identifying 
modifiable factors. PLoS One. 2014. 
22. Belgrave DCM, Granell R, Simpson A, Guiver J, Bishop C, Buchan I, et al. Developmental 
Profiles of Eczema, Wheeze, and Rhinitis: Two Population-Based Birth Cohort Studies. PLoS 
Med. 2014;11(10):e1001748. 
23. Turner S, Thomas M, von Ziegenweidt J, Price D. Prescribing trends in asthma: a longitudinal 
observational study. Archives of Disease in Childhood. 2009;94(1):16-22. 
24. Simpson CR, Newton J, Hippisley-Cox J, Sheikh A. Trends in the epidemiology and 
prescribing of medication for eczema in England. J R Soc Med. 2009;102(3):108-17. 
25. Ghouri N, Hippisley-Cox J, Newton J, Sheikh A. Trends in the epidemiology and prescribing 
of medication for allergic rhinitis in England. J R Soc Med. 2008;101(9):466-72. 
26. Osman M, Hansell AL, Simpson CR, Hollowell J, Helms PJ. Gender-specific presentations 
for asthma, allergic rhinitis and eczema in primary care. Primary Care Respiratory Journal. 
2007;16(1):28-35. 
 
